Log in to save to my catalogue

Small molecule inhibitors of [alpha]-synuclein oligomers identified by targeting early dopamine-medi...

Small molecule inhibitors of [alpha]-synuclein oligomers identified by targeting early dopamine-medi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A686447986

Small molecule inhibitors of [alpha]-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

About this item

Full title

Small molecule inhibitors of [alpha]-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

Publisher

BioMed Central Ltd

Journal title

Molecular neurodegeneration, 2021-11, Vol.16 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background Parkinson's disease is a disabling neurodegenerative movement disorder characterized by dopaminergic neuron loss induced by [alpha]-synuclein oligomers. There is an urgent need for disease-modifying therapies for Parkinson's disease, but drug discovery is challenged by lack of in vivo models that recapitulate early stages of neurodegener...

Alternative Titles

Full title

Small molecule inhibitors of [alpha]-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A686447986

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A686447986

Other Identifiers

ISSN

1750-1326

E-ISSN

1750-1326

DOI

10.1186/s13024-021-00497-6

How to access this item